What to Know for the 2022-2023 Flu Season

According to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and...

Read More

Biosimilars Versus Interchangeability: What You Need to Know

Specialty medications continue to be a large source of drug spend, in particular biologic drugs. Biosimilars pose an...

Read More

Demonstrating the Value of Specialty Medications that Treat Cystic Fibrosis

Cystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000...

Read More

Demonstrating the Value of Specialty Medications that Treat Various Cancers

Approximately 40% of Americans will be diagnosed with some type of cancer in their lifetime. Many cancer treatments...

Read More

Demonstrating the Value of Specialty Medications that Treat Multiple Sclerosis

There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow...

Read More

Demonstrating the Value of Specialty Inflammatory Medications

Inflammatory medications are one of the top drivers of specialty drug spend. While these costly drugs can provide...

Read More

Biosimilar Basics: Understanding the Difference Between Generics and Biosimilars

With rising drug costs, we’re all looking for ways to reduce out-of-pocket spend without sacrificing quality. Generic...

Read More

The Journey of Orphan Drugs: History, Development and Costs

Recent attention has been given to rare or orphan diseases—more specifically, to the costs associated with the drugs...

Read More

Embattled Alzheimer's Drug Aduhelm: What You Need to Know

Alzheimer’s is a devastating and deadly disease that affects an estimated 6.5 million Americans age 65 and older, or...

Read More

The Path Back to Normal: Your Questions Answered About COVID-19 Vaccinations

The COVID-19 pandemic has had worldwide impact on our daily lives, creating a new “normal” for most of us. In December...

Read More